Fig. 1From: Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseasesLabel claim% of MBA and PBA in the L-arginine solution in function of time. Label claim % of MBA (grey) and PBA (black) included in the L-arginine solution after storage at 5 °C (●) or 25 °C and 60%RH (■)Back to article page